Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands		12 Months Ended
		Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Biosecurity revenue:
Total revenue		$ 251,455	$ 477,706	$ 313,837
Costs and operating expenses:
Research and development		580,621	1,052,643	1,149,662
General and administrative		385,025	1,429,799	862,952
Impairment of lease assets		96,210	0	0
Total operating expenses		1,115,861	2,686,658	2,142,304
Loss from operations		(864,406)	(2,208,952)	(1,828,467)
Other income (expense):
Interest income		57,217	20,262	837
Interest expense		(93)	(106)	(2,373)
Loss on equity method investments		(2,635)	(43,761)	(77,284)
Loss on investments		(54,827)	(53,335)	(11,543)
Change in fair value of warrant liabilities		5,168	124,970	58,615
Gain on settlement of partnership agreement		0	0	23,826
(Loss) gain on deconsolidation of subsidiaries		(42,502)	31,889	0
Other income (expense), net		9,138	7,634	(1,733)
Total other income (expense), net		(28,534)	87,553	(9,655)
Loss before income taxes		(892,940)	(2,121,399)	(1,838,122)
Income tax benefit		(71)	(15,027)	(1,480)
Net loss		(892,869)	(2,106,372)	(1,836,642)
Loss attributable to non-controlling interest		0	(1,443)	(6,595)
Net loss attributable to Ginkgo Bioworks Holdings, Inc. stockholders		$ (892,869)	$ (2,104,929)	$ (1,830,047)
Net loss per share attributable to Ginkgo Bioworks Holdings, Inc. common stockholders:
Basic (in dollars per share)		$ (0.46)	$ (1.25)	$ (1.35)
Diluted (in dollars per share)		$ (0.46)	$ (1.25)	$ (1.39)
Weighted average common shares outstanding:
Basic (in shares)		1,944,420,000	1,679,061,000	1,359,849,000
Diluted (in shares)		1,944,420,000	1,679,839,000	1,360,373,000
Comprehensive loss:
Net loss		$ (892,869)	$ (2,106,372)	$ (1,836,642)
Other comprehensive loss:
Foreign currency translation adjustment		4,116	(917)	(1,715)
Total other comprehensive gain (loss)		4,116	(917)	(1,715)
Comprehensive loss		(888,753)	(2,107,289)	(1,838,357)
Cell Engineering revenue
Biosecurity revenue:
Total revenue	[1]	143,531	143,666	112,989
Product
Biosecurity revenue:
Total revenue		28,949	35,455	23,040
Costs and operating expenses:
Cost of Biosecurity product and service revenue		7,481	20,646	20,017
Service
Biosecurity revenue:
Total revenue		78,975	298,585	177,808
Costs and operating expenses:
Cost of Biosecurity product and service revenue		$ 46,524	$ 183,570	$ 109,673

[1] Includes related party revenue of $22,222, $38,813, and $47,161 for the years ended December 31, 2023, 2022, and 2021, respectively.